GGrantIndex
Sort

17,828 grants matching crispr

The identification of natural variants that contribute to a long circadian period in Drosophila melanogaster

$220,383
Susan Harbison · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL

Discovering the mechanisms of-action-mistargeted anti-cancer agents

$220,368
Jason Sheltzer · Yale University · R01 · FY2022 · CA

Notch signaling in cardiomyocyte transcriptome signatures

$220,290
Jared Churko · University Of Arizona · R00 · FY2020 · HL

Ligand-directed therapeutic CRISPR/Cas gene editing in tumor cells

$220,193
Renata Pasqualini · Rutgers Biomedical And Health Sciences · R21 · FY2024 · CA

Epigenetic gene regulation in the germline

$220,141
Satoshi Namekawa · University Of California At Davis · R35 · FY2022 · GM

Modeling CRISPR to Preserve Antibiotics

$220,050
Michael S. Gilmore · Massachusetts Eye And Ear Infirmary · R21 · FY2013 · GM

Systems for rapid generation of zebrafish mutants and zebrafish embryo handling

$219,931
Raheel Samuel · Nanonc, Inc. · R43 · FY2020 · OD

Uncovering Gene Expression Differences between Benign and Premalignant Colorectal Polyps

$219,902
Eduardo Vilar Sanchez · University Of Tx Md Anderson Can Ctr · R21 · FY2017 · CA

Genetic regulators of vascular smooth muscle thermogenic differentiation

$219,764
Matthew D Lynes · Mainehealth · P20 · FY2021 · GM

Novel In Vitro and In Vivo Bioluminescent Assays of Giardia Cellular Functioning

$219,742
Scott C Dawson · University Of California At Davis · R21 · FY2016 · AI

Virology and Immunology Technology Core

$219,686
Mohamed Abdel Mohsen · Northwestern University At Chicago · P30 · FY2025 · AI

Toward a Complete Set of Germline Null and Modifiable Mutations in Drosophila

$219,679
Ming Fa · Genetivision Corporation · R43 · FY2014 · GM

Mechanistic Studies of CRISPR-Medicated Bacterial Immunity

$219,420
Rakhi Rajan · University Of Oklahoma · P20 · FY2015 · GM

Mechanistic Studies of CRISPR-Medicated Bacterial Immunity

$219,420
Rakhi Rajan · University Of Oklahoma · P20 · FY2016 · GM

Mechanistic Studies of CRISPR-Medicated Bacterial Immunity

$219,419
Rakhi Rajan · University Of Oklahoma · P20 · FY2014 · GM

Building a Comprehensive Discovery System for Understanding Bacterial Multidrug Resistance and Pathogenesis Using Tn7-like Elements

$219,356
Joseph E Peters · Cornell University · R21 · FY2021 · AI

Synthetic lethal metabolic drug combinations for castration-resistant prostate cancer

$219,240
Laura A. Sena · Johns Hopkins University · K08 · FY2025 · CA

Synthetic lethal metabolic drug combinations for castration-resistant prostate cancer

$219,240
Laura A. Sena · Johns Hopkins University · K08 · FY2024 · CA

Synthetic lethal metabolic drug combinations for castration-resistant prostate cancer

$219,240
Laura A. Sena · Johns Hopkins University · K08 · FY2023 · CA

Rewiring of epigenetic DNA damage response pathways in HPV-induced cancer

$219,210
Michael Goldstein · Johns Hopkins University · K08 · FY2023 · CA

Rewiring of epigenetic DNA damage response pathways in HPV-induced cancer

$219,210
Michael Goldstein · Johns Hopkins University · K08 · FY2024 · CA

Rewiring of epigenetic DNA damage response pathways in HPV-induced cancer

$219,210
Michael Goldstein · Johns Hopkins University · K08 · FY2025 · CA

Rewiring of epigenetic DNA damage response pathways in HPV-induced cancer

$219,210
Michael Goldstein · Johns Hopkins University · K08 · FY2022 · CA

Rewiring of epigenetic DNA damage response pathways in HPV-induced cancer

$219,209
Michael Goldstein · Washington University · K08 · FY2021 · CA

Project 3: Repurposing Ceritinib for Ovarian Cancer Therapy

$219,183
Larry M Karnitz · Mayo Clinic Rochester · P50 · FY2024 · CA